Gene Therapy Developments for Pompe DiseaseZeenath Unnisa, Niek P. van Til, John K. Yoon et al.|Biomedicines|2022Cited by 51
Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe diseaseYildirim Dogan, Niek P. van Til, Richard W. Pfeifer et al.|Molecular Therapy — Methods & Clinical Development|2022Cited by 16
High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosingRobert N. Plasschaert, Chris Mason, Mark P. DeAndrade et al.|Molecular Therapy|2022Cited by 13
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestationsJohn K. Yoon, Niek P. van Til, Jeffrey W. Schindler et al.|Molecular Therapy|2024Cited by 5
Genetically engineered microglia-like cells have therapeutic potential for neurodegenerative diseaseRobert N. Plasschaert, Chris Mason, Mark P. DeAndrade et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2